Back to search
FDAFDA · Food and drugs·Recall number Z-1283-2024

LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004

Published March 20, 2024 · Recall initiated: May 10, 2023

Summary

FDA records medical device Class II recall Z-1283-2024, published March 20, 2024 and initiated May 10, 2023. Recalling firm: Fresenius Kabi USA, LLC; Status: Completed; Reported quantity: 6 US; Lot: UDI-DI 00811505030122 Software versions 5.2.1/5.2.2. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.

What to do

Voluntary: Firm initiated · Other

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
US Nationwide distribution to the states of CA, CO, NJ, WI, UT.
Lot
UDI-DI 00811505030122 Software versions 5.2.1/5.2.2
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was LVP software of the Ivenix Infusion System (IIS); LVP-SW-0004 recalled?

Yes. FDA published recall Z-1283-2024 on March 20, 2024. Reported hazard: Retroactively reported corrections from 2023: 1) A software defect may cause an incorrect (Fail-Stop) alarm when an administration set is loaded or coupled while the pump is executing the power-up sequence. May lead to delay in therapy. 2) Alert is not annunciated informing the clinician that the bolus cannot be delivered when the entered bolus dose exceeds the Care Profile Hard Rate Max limit and Rapid Bolus is selected. May lead to over infusion. Both issues were resolved in all fielded product in software version 5.8.0, which was installed in affected units May thru August 2023.

What should I do if I have this product?

Voluntary: Firm initiated · Other